Research programme: PPAR alpha agonists - Chipscreen Biosciences

Drug Profile

Research programme: PPAR alpha agonists - Chipscreen Biosciences

Alternative Names: CS 207; CS 307

Latest Information Update: 06 Apr 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Chipscreen Biosciences
  • Class
  • Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cardiovascular disorders; Lipid metabolism disorders

Most Recent Events

  • 06 Apr 2010 Discontinued for Cardiovascular disorders in China (unspecified route)
  • 06 Apr 2010 Discontinued for Lipid metabolism disorders in China (unspecified route)
  • 15 Aug 2007 Early research in Cardiovascular disorders in China (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top